Articulus Surgical
Saurya Mishra is the Founder and CEO of Articulus Surgical since December 2020. Previously served as the Director of Research and Development at Morphle Labs Pvt. Ltd. from November 2019 to November 2020, focusing on advanced slide imaging techniques and digital pathology solutions. Saurya has a significant tenure at Philips, holding various roles from October 2012 to November 2019, including Mechanical Designer and Project Manager, contributing to the development of innovative healthcare solutions and cost reduction strategies. Earlier experience includes coordinating Team Robotix, the largest robotics fest in South Asia, and an exchange internship at HEIG-VD, implementing programming for humanoid robots. Saurya hold’s multiple degrees from the Indian Institute of Technology, Kharagpur, including a Master of Technology and a Bachelor and Master of Mechanical Engineering.
This person is not in any teams
This person is not in any offices
Articulus Surgical
At Articulus, we are driven by the mission to provide better surgical outcomes to 170 Million patients through affordable and accessible minimally invasive surgical robotics. We believe that every patient deserves better surgical outcomes and every surgeon deserves the tools, technology, and training to make this possible. Our patent-pending product and control system is poised to revolutionize surgical robotics, with a hybrid surgical robot that is 5x more affordable, and 5x more portable compared to the competition while providing state-of-the-art dexterity, precision and ease of learning. Our product is designed to be interoperable with the existing infrastructure of hospitals thereby making on-demand surgical robotics a reality. We are going beyond cost-effectiveness and are leveraging the power of Assistive Intelligence to ensure surgeries are safer and more predictable and to ultimately become the gateway to a true amalgamation of Surgeon, Robot and AI. Our asset-light business model allows us to serve a $40 billion global market, expanding our reach to 5 times more hospitals and clinics than any of our competitors, providing us with a unique opportunity to make a significant impact. In the next decade, we expect one-third of surgeries to be performed using robotics. Articulus is poised to fill the gap left by inadequate current solutions and become a mission-critical asset in surgery.